Patent 7344715 was granted and assigned to Immune System Therapeutics on March, 2008 by the United States Patent and Trademark Office.
The present invention relates to methods for the treatment of multiple myeloma. More particularly, the present invention relates to a method for inducing apoptosis in myeloma cells by administration of a K121-like antibody.